You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康芝藥業(300086.SZ)業績快報:2019年由盈轉虧 淨虧損2259.25萬元
格隆匯 02-28 22:06

格隆匯2月28日丨康芝藥業(300086.SZ)披露2019年度業績快報,報告期內,公司實現營業總收入10.08億元,同比上升14.22%;營業利潤-451.75萬元;利潤總額-370.24萬元;歸屬於上市公司股東的淨虧損2259.25萬元,上年同期盈利1336.62萬元;基本每股虧損0.0502元。其利潤下降的主要原因如下:

1、2019年度對比2018年度同期營業收入規模有較明顯增長,綜合毛利率水平有所增加。但為保持營業收入規模增長以及深化各業務板塊渠道發展需要,2019年度的銷售費用、管理費用對比2018年度同期有所增加。

2、為發展、保持公司未來競爭力,2019年度公司對部分藥品生產子公司進行產能整合,因此,2019年度管理費用職工安置支出對比2018年度同期增長明顯,目前與職工安置相關工作已經進入尾聲,預計不會對後續年度經營業績產生重大影響。

3、為發展、保持公司未來競爭力,2019年度研發費用投入對比2018年度同期有所增加。

4、因匯率波動因素影響,2019年度匯兑損失對比2018年度同期有明顯增加。

5、由於2018年6月起使用募集資金及部分自有資金逐步完成股權收購業務,因此2019年度對比2018年度同期銀行理財產生的投資收益明顯減少。

6、根據會計準則的規定,2019年度轉回遞延所得税資產金額對比2018年度同期有所增加。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account